DOI
10.1142/s0192415x20500743
Development of Rapid Advice Guidelines for the Treatment of Coronavirus Disease 2019 with Traditional Chinese Medicine
作者地址
China Acad Chinese Med Sci, Inst Basic Res Clin Med, 16 Dong Zhi Men Nei Nan Xiao Jie, Beijing 100700, Peoples R China
通讯作者
Wang, Yanping;Shi, Nannan;Chen, Yaolong
来源期刊
Am J Chin Med
ISSN
0192-415X
EISSN
1793-6853
出版日期
2020-07-12
卷号
48
期号
7
页码
1511-1521
摘要
The worldwide spread of the 2019 novel coronavirus has become a profound threat to human health. As the use of medication without established effectiveness may result in adverse health consequences, the development of evidence-based guidelines is of critical importance for the clinical management of coronavirus disease (COVID-19). This research presents methods used to develop rapid advice guidelines on treating COVID-19 with traditional Chinese medicine (TCM). We have followed the basic approach for developing WHO rapid guidelines, including preparing, developing, disseminating and updating each process. Compared with general guidelines, this rapid advice guideline is unique in formulating the body of evidence, as the available evidence for the treatment of COVID-19 with TCM is from either indirect or observational studies, clinical first-hand data together with expert experience in patients with COVID-19. Therefore, our search of evidence not only focuses on clinical studies of treating COVID-19 with TCM but also of similar diseases, such as pneumonia and influenza. Grading of recommendations assessment, development and evaluation (GRADE) methodology was adopted to rate the quality of evidence and distinguish the strength of recommendations. The overall certainty of the evidence is graded as either high, moderate, low or very low, and to give either "strong" or "weak" recommendations of each TCM therapy. The output of this paper will produce the guideline on TCM for COVID-19 and will also provide some ideas for evidence collection and synthesis in the future development of rapid guidelines for COVID-19 in TCM as well as other areas.
资助信息
National Key Research & Development Plan (No. 2019YFC1712000);National Science and Technology Major Project (No. 2018ZX10101001-005)
资助机构
National Key Research & Development Plan ; National Science and Technology Major Project
语种
English
国家
学科领域
收录类别
SCIE
WOS学科分类
Integrative & Complementary Medicine ; Medicine, General & Internal
WOS关键词
Author Keywords:Corona Virus Disease 2019 ; COVID-19 ; 2019-nCoV ; Traditional Chinese Medicine ; TCMRapid Advice Guidelines ; Review Keywords Plus:QUALITY ; CARE ; TOOL
被引频次(WOS)
12
研究类型
方法学

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。